Neuland Laboratories Ltd. - Company Profile

Q: Where is Neuland Laboratories Ltd. headquartered?

Neuland Laboratories Ltd. is headquartered at 11Th Floor 5Th Level, Phoenix Ivy Building, Plot No. 573A-Iii, Road No. 82, Jubilee, Hills,, Hyderabad, Telangana, 500033.

Q: Who are the current directors of Neuland Laboratories Ltd.?

The current directors of Neuland Laboratories Ltd. are Prasad Raghava Menon, Homi Rustam Khusrokhan, Pallavi Joshi Bakhru, Ramamohan Davuluri Rao, Saharsh Rao Davuluri, Sugata Sircar, Sucheth Rao Davuluri, Sarada Bhamidipati, Christopher Cimarusti M, Abhijit Ajay Majumdar, Ravi Shankar Gopinath.

It is a pharma public limited company based in Hyderabad, Telangana, India, established in 1984.

1984 Hyderabad, Telangana, India Active

Last Updated: January 06, 2026

Access Report

About Neuland Laboratories Ltd.

Neuland Laboratories Ltd., a active public limited company, was established on 07 January 1984 in Hyderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: L85195TG1984PLC004393. Registered under ROC Roc Hyderabad. it is listed on BSE: 524558 and NSE: NEULANDLAB. It has an authorized capital of ₹44.00 Cr and a paid-up capital of ₹12.83 Cr.

Formerly known as Neuland Laboratories Private Limited. It upholds a compliant status. In 2023, it reported revenue of ₹1,200.95 Cr and a net worth of ₹988.36 Cr. Employing 1,860 professional, Its leadership includes Prasad Raghava Menon (Director), Homi Rustam Khusrokhan (Director), Pallavi Joshi Bakhru (Director). Past directors included Prasad Raghava Menon, Sai Ram Edara, Pallavi Joshi Bakhru. It holds ₹1,091.88 Cr open charges and ₹2,289.23 Cr settled loans. Its latest AGM occurred on 30 July 2025, with the balance sheet filed on 31 March 2025. It is based at 11Th Floor (5Th Level), Phoenix Ivy Building, Plot No. 573A-Iii, Road No. 82, Jubilee, Hills,, Hyderabad, Telangana, 500033.

Company Details

CIN/LLPIN
L85195TG1984PLC004393
Registration Number
004393
Incorporation Date
07 January 1984
Authorized Capital
₹44.00 Cr
Paid-Up Capital
₹12.83 Cr
ROC Code
Roc Hyderabad
Listing Status
Listed (BSE: 524558, NSE: NEULANDLAB)
Company Status
Active

Key Metrics

Authorised Capital ₹ 44.00 Cr as on 06-01-2026
Paid Up Capital ₹ 12.83 Cr as on 06-01-2026
Company Age 42 Year, 1 Month
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 1,091.88 Cr as on 06-01-2026
Satisfied Charges ₹ 2,289.23 Cr as on 06-01-2026
Revenue Growth **** 26.00% (FY 2023)
Profit Growth **** 156.75% (FY 2023)
Ebitda **** 90.80% (FY 2023)
Net Worth 18.29% (FY 2023)
Total Assets **** 14.27% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Neuland Laboratories Ltd. — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Neuland Laboratories Ltd.?

Current Directors

Name	Designation	Appointment Date	Status
Prasad Raghava Menon	Director	31 Oct 2022	Current
Homi Rustam Khusrokhan	Director	12 Feb 2019	Current
Pallavi Joshi Bakhru	Director	27 Jun 2023	Current
Ramamohan Davuluri Rao	Whole-Time Director	07 Jan 1984	Current
Saharsh Rao Davuluri	Whole-Time Director	01 Jun 2009	Current
Sugata Sircar	Director	27 Jun 2023	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	22 Dec 2022	Past
Pramod Abcsdd	Company Secretary	15 Nov 2007	Past
Pramod Abcsdd	Additional Director	26 Jul 2023	Past
Pramod Abcsdd	Company Secretary	02 Apr 2009	Past
Pramod Abcsdd	Managing Director	04 Aug 2020	Past
Pramod Abcsdd	Cfo(Kmp)	-	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Neuland Laboratories.

Neuland Laboratories Ltd., for the financial year ended 2023, experienced significant growth in revenue, with a 26% increase. The company also saw a substantial improvement in profitability, with a 156.75% increase in profit. The company's net worth Soared by an impressive increase of 18.29%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

26.00%

*******

Revenue from Operations

*******

25.25%

*******

Total Assets

*******

14.27%

*******

Profit or Loss

*******

156.75%

*******

Net Worth

*******

18.29%

*******

EBITDA

*******

90.80%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Neuland Laboratories?

In 2023, Neuland Laboratories had a promoter holding of 36.14% and a public holding of 63.86%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹10,918,821,721.00

Satisfied Charges

₹22,892,280,000.00

Charges Breakdown by Lending Institutions

Sbicap Trustee Company Limited : 1088.75 Cr
Axis Bank Limited : 3.13 Cr

Latest Charge Details

Date	Lender	Amount	Status
27 Nov 2023	Axis Bank Limited	₹2.71 Cr	Open
29 Jul 2022	Sbicap Trustee Company Limited	₹1,088.75 Cr	Open
22 Jul 2020	Axis Bank Limited	₹4.24 M	Open
18 Mar 2025	Others	₹190.00 Cr	Satisfied
26 Apr 2024	State Bank Of India	₹95.00 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Neuland Laboratories?

Neuland Laboratories has a workforce of 1860 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Neuland Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neuland Laboratories's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Neuland Laboratories

Recent Activity within the Organization

Charges

Progress on A charge registered on 18 Mar 2025 via Charge ID 101076510 with Others was fully satisfied on 18 Nov 2025. was documented.
18 Nov 2025
Charges

A charge with Sbicap Trustee Company Limited of Rs. 1,088.75 Cr registered on 29 Jul 2022 with Charge ID 100603089 was modified on 27 Oct 2025. was recorded as a recent event.
27 Oct 2025
Director Appointment

Progress on Ravi Shankar Gopinath was appointed as a Additional Director was appointed as a Additional Director on 01 Aug 2025 & has been associated with this company since 6 months 12 days . was documented.
01 Aug 2025
Annual General Meeting

Progress on Neuland Laboratories Ltd. last Annual general meeting of members was held on 30 Jul 2025 as per latest MCA records. was documented.
30 Jul 2025
Balance Sheet

Progress on Neuland Laboratories Ltd. has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.
31 Mar 2025
Charges

Progress on A charge with Others amounted to Rs. 190.00 Cr with Charge ID 101076510 was registered on 18 Mar 2025. was documented.
18 Mar 2025

Explore recent activity and updates - View Recent Activity